Christopher M. Conway serves as Executive at ALBANY MOLECULAR RESEARCH INC, where they oversee executive responsibilities. Since joining the company, Christopher M. Conway has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 31, 2017 involved selling 47,477 shares valued at $1.0M.
Christopher M. Conway currently holds 47,477 shares of ALBANY MOLECULAR RESEARCH INC (AMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher M. Conway has been a net neutral trader of AMRI stock. They have purchased $0 and sold $0 worth of shares.
Christopher M. Conway's most recent insider trade was on Aug 31, 2017, when they sold 47,477 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 2, 2017 | AMRI | $3.9K | Payment | 271 | $14.52 | Discretionary |